Background and rationaleIrritable bowel syndrome (IBS), a core disorder of gut–brain interaction, remains one of the most common and heterogeneous ...
An oncology expert explains how clinical and non-clinical evidence impact the clinical pathway decision-making for patients with NSCLC. Edward Arrowsmith, MD: We have a couple ways that we're tracking ...
The free virtual series extends Clinical Pathways Congress with timely insights into evidence-based pathways, value assessment, and access. By extending Clinical Pathways Congress throughout the year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results